14.1 Professional Practice: Guidelines, Ethics, Legislation, Outreach & Accreditation
Key Takeaways
Breast care nurses draw on NCCN, ASCO, ONS, ACS, ACR, and ASBrS guidelines and the ONS/ANA Scope and Standards of Oncology Nursing Practice.
The CDC National Breast and Cervical Cancer Early Detection Program provides free or low-cost screening for eligible low-income, uninsured, and underinsured women.
The Breast and Cervical Cancer Prevention and Treatment Act of 2000 lets states offer Medicaid treatment coverage to women diagnosed through the national early detection program.
The Affordable Care Act requires most health plans to cover recommended screening mammography and BRCA-related counseling and testing without cost sharing.
NAPBC-accredited centers must meet standards for interdisciplinary conferences, navigation, psychosocial distress screening, genetics, and survivorship services.
Practice Guidelines and Standards
Breast care nursing practice rests on evidence-based guidelines:
| Source | What it provides |
|---|---|
| NCCN Guidelines | Stage-based diagnosis and treatment algorithms, genetics, survivorship, supportive care |
| ASCO guidelines | Focused recommendations (for example, surveillance, antiemetics, male breast cancer, genetic testing) |
| ONS guidelines and resources | Chemotherapy and immunotherapy safety, symptom management evidence (Putting Evidence Into Practice) |
| ACS and ACR | Screening and imaging recommendations |
| American Society of Breast Surgeons | Surgical quality and consensus statements |
| ONS/ANA Scope and Standards of Oncology Nursing Practice | Professional role, competencies, and performance standards |
Guidelines are updated often. Nurses verify the current version, recognize when patients fall outside guideline populations, and help translate recommendations into individualized plans.
Professional Nursing Ethics & Informed Consent
Foundational Ethical Principles in Breast Care Nursing
- Autonomy: Respecting the patient as an independent moral agent with the absolute right to make self-determined decisions regarding their own body and medical treatment. Nurses uphold autonomy by facilitating objective education and ensuring patients are never coerced into decisions favored by clinicians or family members.
- Beneficence: The moral obligation to act in the best interest of the patient, promoting their physical health, emotional well-being, and recovery.
- Non-Maleficence: The foundational duty to 'do no harm'—minimizing physical pain, procedural complications, psychological distress, and avoiding medically futile or non-indicated interventions.
- Justice: The ethical imperative to provide fair, equitable, non-discriminatory care to all patients regardless of race, ethnicity, socioeconomic status, gender identity, or insurance coverage.
Informed Consent and Shared Decision-Making
Informed consent in breast oncology is an ongoing communicative process rather than a static signature on a legal form. Many breast cancer interventions represent preference-sensitive decisions where multiple medically reasonable options exist with differing risk-benefit profiles (e.g., breast-conserving surgery plus radiation vs. mastectomy; immediate vs. delayed reconstruction; extended adjuvant endocrine therapy for 5 vs. 10 years).
- The Shared Decision-Making (SDM) Model: Clinicians and patients collaborate as partners, integrating scientific clinical evidence with the patient's unique personal values, lifestyle priorities, risk tolerance, and aesthetic preferences (utilizing validated decision aids, such as the Ottawa Decision Support Framework).
- Nursing Responsibilities in Informed Consent:
- Assess patient comprehension: Verify that the patient understands the nature of the diagnosis, the proposed procedure or therapy, realistic expected benefits, material risks and potential complications, alternative treatment options (including the option of no treatment), and the consequences of refusal.
- Evaluate voluntary decision-making: Ensure the consent is entirely voluntary, free from institutional or familial coercion.
- Verify provider disclosure: Ensure the treating physician or surgeon has personally held the detailed informed consent discussion prior to witnessing the patient's signature.
- Protect vulnerable populations: Ensure health literacy, language barriers, or acute situational distress do not compromise understanding.
Shared Decision-Making Tools
Preference-sensitive decisions, such as lumpectomy with radiation versus mastectomy, reconstruction choices, contralateral prophylactic mastectomy, and extended endocrine therapy, are good candidates for decision aids that meet International Patient Decision Aid Standards. Nurses use teach-back ("Tell me in your own words what the choices are") to confirm understanding, and they explore values such as avoiding radiation, body image, recurrence worry, and recovery time. A nurse's role is to support the patient's informed choice, not to steer it.
Legislative Issues Affecting Breast Care
| Law or program | What it does |
|---|---|
| Breast and Cervical Cancer Mortality Prevention Act (1990) | Created the CDC National Breast and Cervical Cancer Early Detection Program (free or low-cost screening and diagnostics for eligible low-income, uninsured, and underinsured women) |
| Breast and Cervical Cancer Prevention and Treatment Act (2000) | Lets states provide Medicaid treatment coverage to women diagnosed through the early detection program |
| Women's Health and Cancer Rights Act (1998) | Plans that cover mastectomy must cover reconstruction, symmetry surgery, prostheses, and lymphedema treatment, with no time limit |
| Genetic Information Nondiscrimination Act (2008) | Bars genetic discrimination in health insurance and employment; excludes life, disability, and long-term care insurance |
| Affordable Care Act (2010) | Requires coverage without cost sharing for USPSTF-recommended preventive services, including screening mammography, BRCA-related risk assessment, counseling, and testing, and risk-reducing medications for eligible women |
| MQSA breast density rule (effective September 10, 2024) | Mammography reports and patient letters must state whether breasts are dense and explain that density can hide cancer and raise risk |
| Lymphedema Treatment Act (effective January 1, 2024) | Medicare Part B coverage for compression garments and supplies |
| Family and Medical Leave Act; Americans with Disabilities Act | Job-protected leave and workplace accommodations for patients and caregivers |
Nurses advocate through professional organizations (for example, ONS legislative action), by informing patients of their rights, and by contacting legislators about issues such as supplemental imaging coverage and drug costs.
Community Outreach
Effective outreach reaches people where they live and addresses specific barriers:
- Mobile mammography and screening events at workplaces, churches, and community centers.
- Community health workers and lay navigators who share the language and culture of the community.
- Culturally tailored education that addresses fatalism, modesty, and myths.
- Partnerships with early detection programs, federally qualified health centers, and faith-based organizations.
- Evaluation of outreach using measurable outcomes such as screening completion and time to diagnostic resolution.
Evidence-Based Practice
Evidence-Based Practice represents the lifelong clinical process of integrating the best available scientific research evidence with clinical nursing expertise and patient values and preferences (utilizing structured frameworks such as the Iowa Model or the Johns Hopkins Nursing EBP Model). EBP empowers breast care nurses to eliminate obsolete rituals, standardize clinical workflows, and optimize patient outcomes.
National Accreditation Program for Breast Centers (NAPBC)
The National Accreditation Program for Breast Centers (NAPBC), administered by the American College of Surgeons (ACS), establishes rigorous, interdisciplinary quality standards for comprehensive breast care centers. NAPBC accreditation signifies that a breast center delivers state-of-the-art diagnostic, surgical, systemic, and supportive care.
Key NAPBC standards directly driven by nursing leadership include:
- Standardized Diagnostic Resolution: Ensuring patients with abnormal screening mammograms achieve diagnostic resolution (imaging and biopsy) within benchmarked timeframes.
- Multidisciplinary Case Presentation: Prospective presentation of newly diagnosed breast cancers at multidisciplinary tumor boards prior to initiating definitive therapy.
- Psychosocial Distress Screening: Screening with a validated instrument (such as the NCCN Distress Thermometer) at least once during the first course of treatment, with a process for referral; many programs screen at additional transition points.
- Dedicated Patient Navigation: Employment of trained oncology nurse navigators to assist patients across the continuum.
- Survivorship Program: A survivorship program with services such as treatment summaries, follow-up care plans, rehabilitation, and psychosocial support (current standards emphasize a program rather than mandating individual care plans).
- Genetics and Risk Assessment: Access to cancer risk assessment, genetic counseling, and testing by qualified professionals.
Other quality frameworks include the Commission on Cancer (for cancer programs), the National Quality Measures for Breast Centers program, ASCO's Quality Oncology Practice Initiative, and Magnet recognition for nursing excellence.
A 48-year-old uninsured woman with a household income below the local eligibility limit has not had a mammogram because of cost. Which resource should the nurse connect her with?
The CDC National Breast and Cervical Cancer Early Detection Program
The Women's Health and Cancer Rights Act
The Genetic Information Nondiscrimination Act
The Lymphedema Treatment Act
A patient choosing between lumpectomy with radiation and mastectomy says, "Just tell me what you would do." Which nursing approach best supports shared decision-making?
Tell her mastectomy is always safer so she avoids radiation.
Refer the decision to her spouse to reduce her stress.
Use a decision aid, explain that survival is equivalent for eligible patients, explore what matters most to her, and confirm understanding with teach-back.
Advise her to delay the decision until after chemotherapy.
A patient's screening mammogram letter says she has dense breast tissue. She asks why this notice is now included. What is the accurate explanation?
It means she has breast cancer and needs a biopsy.
Since September 2024, FDA rules under MQSA require facilities to tell patients whether their breasts are dense, because density can hide cancer and is linked to higher risk.
Only some states allow facilities to mention density.
Dense tissue is reported only when the mammogram is abnormal.
Sections you finish are checked off in the contents.